secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-06-29T10:03:19+00:00
Accession:  0001193125-26-286737
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Decoy Therapeutics raises $3.5M upfront in PIPE, up to $21M with milestone warrants
--------------------------------------------------------------------------------

- Gross proceeds of $3.5M from sale of 592,217 shares (or pre-funded warrants) at $5.91/share.
- Milestone warrants could add $3.5M (Series A), $7.0M (Series B), and $7.0M (Series C) if triggered.
- Proceeds to advance lead asset into clinical trials; closing expected June 29, 2026.
- Executives and directors subject to 90-day lock-up; Curvature Securities acting as placement agent.
- Registration rights agreement requires filing resale registration statement within 15 calendar days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/0001193125-26-286737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/dcoy-20260626.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-286737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer